221 Poster Multimodal, <strong>Chemosensory</strong> Measurement,Psychophysical, Clinical Olfactory, and TrigeminalMEASURES OF CONFUSION AND SIMILARITY BETWEENBITTER TASTE AND BURNING SENSATIONLim J. 1 , Green B. 1 1 The John B. Pierce Laboratory, New Haven, CTAlthough it has long been studied as a pure irritant, capsaicin can alsoevoke and desensitize bitter taste. This suggests that bitter taste andburning sensation might be closely related perceptually. The currentstudy investigated the psychophysical relationship between bitternessand burning using two different approaches. In Exp. 1, spatialdiscrimination of four basic tastes was measured in the presence orabsence of capsaicin. Subjects reported which of three swabs spaced 1cm apart and presented to the tongue tip contained a taste stimulus when(1) water was presented on the other two swabs, or (2) when 10 µMcapsaicin was presented on all three swabs. The presence of capsaicindid not change performance on the 3-AFC task for sweet, sour and saltystimuli, while the localization error for 1.8-mM QSO 4 significantlyincreased (p = 0.03). In Exp. 2, the overall similarity/dissimilarity oftaste stimuli and capsaicin was measured directly. All combinations offour taste stimuli and capsaicin were applied in pairs to opposite sidesof the tongue tip on swabs separated by 2 cm. Multidimensional scalinganalyses applied to the similarity ratings showed that capsaicin fellnearer to QSO 4 than to any other taste stimuli. Cluster analysiscorroborated this finding: capsaicin was closely linked with QSO 4 , andthe capsaicin-QSO 4 group was separated from the other taste stimuli.The results also indicated that bitterness was more similar to burningthan to the other basic taste qualities. These findings imply thatbitterness and burn may be functionally related as sensory signals ofpotentially dangerous stimuli. Supported in part by NIH grantDC005002.222 Poster Multimodal, <strong>Chemosensory</strong> Measurement,Psychophysical, Clinical Olfactory, and TrigeminalGUSTATORY–OLFACTORY MIXTURES: A CONFUSIONMATRIX STUDYMunoz D.M. 1 , Frank M.E. 1 , Gent J.F. 2 , Hettinger T.P. 1 1 Oral Health &Diagnostic Sciences, UCONN Health Center, Farmington, CT;2 Epidemiology & Public Health, Yale University, New Haven, CTGustation may dominate olfaction in taste-odor mixtures (Laing etal., 2002). We measured identification of odors and tastes in binarymixtures after water or chlorhexidine rinses with a 10-stimuluschemosensory confusion matrix (CCM): 100 mM NaCl, 300 mMsucrose, 100 µM phenethyl alcohol, 30 µM vanillin, 4 taste-odormixtures, 1 odor-odor mixture and water. The odorant concentrationsused did not linger and were reliably identified retronasally. Stimuliwere presented to 10 subjects twice in separate sessions with differenttreatment rinses: 1.34 mM chlorhexidine, an oral antiseptic that reducessalty taste intensity (Frank et al., 2001), or deionized water, in a crossover design. Percent correct identification and two measures derivedfrom information theory: T10 and T2 (Hettinger et al., 1999), werecalculated and analyzed with ANOVA and post hoc t-tests. In taste-odormixtures, tastants were identified more frequently (92% correct) thanodorants (60% correct) [t(7) = 5.2, p = 0.001]. Response consistency(T10) was lower after chlorhexidine (1.96 ± 0.12 bits) than after water(2.36 ± 0.16 bits) [t(9) = 4.92, p = 0.0008] and chlorhexidine rinsedecreased discriminability (T2) of NaCl solutions [F(23,207) = 5.1, p =
225 <strong>Symposium</strong> Olfaction in Neurodegenerative DiseaseDETECTION OF PRECLINICAL PARKINSON´S DISEASEALONG THE OLFACTORY TRAC(T)Berendse H.W. 1 1 Neurology, VU University Medical Center,Amsterdam, NetherlandsIn order to determine whether olfactory impairments are a sign ofincipient or preclinical Parkinson´s disease (PD), we set up aprospective study involving a cohort of 361 non-parkinsonian firstdegreerelatives of PD patients, in whom likely alternative causes ofolfactory dysfunction were excluded. Baseline performance on acombination of olfactory tasks (odor detection, odor identification andodor discrimination) was used to select groups of hyposmic (n=40) andnormosmic (n=38) individuals for clinical follow-up and sequential[¹²³I]-CIT SPECT (single-photon emission computed tomography)scanning to assess nigrostriatal dopaminergic function. A validated mailquestionnaire was used in the follow-up of the remaining 283 relatives.Baseline SPECT scans demonstrated a subclinical loss of striatal [¹²³I]ß-CIT binding in some of the hyposmic but in none of the normosmicrelatives (Ann Neurol 2001;50:34-41). Two years from baseline, 10%of the individuals with unexplained hyposmia, who also had stronglyreduced baseline striatal [¹²³I]ß-CIT binding, had developed clinical PDas opposed to none of the other relatives in the cohort (Ann Neurol2004;56:173-181). In the remaining non-parkinsonian hyposmicrelatives, the average rate of decline in striatal [¹²³I]ß-CIT binding wassignificantly higher than in the normosmic relatives. Presently, we areanalyzing the clinical and imaging results of the four year follow-upvisits. The data obtained so far indicate that otherwise unexplainedhyposmia in first degree relatives of patients with sporadic PD isassociated with an increased risk of developing clinical PD. Supportedby Zon-Mw, grant no. 28-3062-01227 Slide Molecular Genetic Approaches toChemoreceptionMOLECULAR IDENTIFICATION OF PACAP-SENSITIVE KCHANNEL EXPRESSION IN OELucero M. 1 , Han P. 1 1 Physiology, University of Utah, Salt Lake City,UTA-type K + currents (I A ) in olfactory sensory neurons have beencharacterized electrophysiologically but the molecular identities of theunderlying channel subunits have not been determined. Using RT-PCR,immunoblot and immunohistochemistry, we found that the channelfamilies underlying I A , shaker and shal, are expressed in mouseolfactory epithelia (OE). Specifically, Kv1.4, from the shaker family,and Kv4.2 and Kv4.3 from the shal family were expressed, but Kv4.1mRNA was not amplified from the OE. Immunoblot andimmunohistochemical studies confirmed the existence of Kv1.4 andKv4.2/3 subunits. Furthermore, quantitative RT-PCR showed thatPACAP reduced the expression of Kv1.4 and Kv4.2 but not Kv4.3. ThePACAP-induced reduction of Kv4.1 and Kv4.2 expression wascompletely blocked by inhibiting the PLC pathway. Inhibition of thecAMP pathway had no effect. In addition, calcium mediated thereduction of both Kv1.4 and Kv4.2 expression and I A current density.PKC activation did not affect Kv1.4 and Kv4.2 mRNA expression, eventhough PKC reduced I A current density. Together with our previousstudies, our data suggest that A-type K + currents in OSNs are comprisedof multiple K + channel subunits, among which Kv1.4 and Kv4.2 aresubject to transcriptional modulation by PACAP. We also found thatPACAP predominately uses a PLC-calcium pathway to modulate Kv4.1and Kv4.2 expression. Modulation of A-type K + current expression maycontribute to the previously observed neuroprotective effects of PACAPon olfactory sensory neurons. Funding: NIH NIDCD-R01DC002994.226 <strong>Symposium</strong> Olfaction in Neurodegenerative DiseaseLONG-TERM CHANGES OF THE OLFACTORY SYSTEM INIDIOPATHIC PARKINSON´S DISEASEHummel T. 1 , Haehner A. 1 , Witt M. 1 , Herting B. 2 , Storch A. 2 , ReichmannH. 2 1 Otorhinolaryngology, University of Dresden, Dresden, Saxony,Germany; 2 Neurology, University of Dresden, Dresden, Saxony,GermanyOlfactory dysfunction is an early sign of idiopathic Parkinson´sdisease (IPD). While this has been established some 30 ago relativelyfew studies investigated long-term changes of the sense ofsmell/structures related to olfactory function. A study on 50 PD patientsfollowed up for 6-12 months revealed that there was no majordifference between olfactory function in IPD subtypes, while allolfactory tests differentiated IPD from non-IPD. Follow-up of caseswith de-novo IPD did not yield a significant decrease of olfactoryfunction.This was further corroborated by a study in a larger group ofIPD patients being followed up over a period of more than 3 years.Again, these patients did not exhibit a significant change of theirolfactory function but remained, on average, at the level of hyposmia.Further, an investigation in 11 IPD patients and 9 healthy, age-matchedcontrols suggested that there is little or no difference between IPDpatients and healthy controls in terms of olfactory bulb volume. Basedupon the relation between loss of olfactory input to the olfactory bulband consecutive decrease in volume, these data support the idea thatolfactory loss in IPD is not a primary consequence of damage to theolfactory epithelium but rather results from central-nervous changesbeyond the olfactory bulb – which is emphasized by recent studies inpatients with Wilson´s disease.228 Slide Molecular Genetic Approaches toChemoreceptionTHE FUNCTIONAL PROPERTIES OF MAMMALIANODORANT RECEPTORSSaito H. 1 , Chi Q. 1 , Zhuang H. 1 , Matsunami H. 1 1 Department ofMolecular Genetics and Microbiology, Duke University, Durham, NCIn order to elucidate the functional properties of mammalian odorantreceptors (ORs), we are performing high-throughout screening of activeligands for human and mouse ORs using HEK293-T cells expressingRTP 1 and 2, and REEP1 We first generated both mouse and human ORlibraries. Based on Olfactory Receptor DataBase (ORDB ;http://senselab.med.yale.edu/senselab/ORDB/default.asp) and thepublished data from Firestein´s lab (Nature Neurosci. 5, 124-133 2002),300 human and 250 mouse odorant receptors were chosen andsubcloned into the expression vectors. The screening was done by acAMP-dependent luciferase assay. First the activity of these receptorswas tested with mixture of odorants and then examined with individualodorants at several different concentrations. From these subsequentexperiments, 20 human and 80 mouse ORs were found to be activatedby some of the compounds from a group of 78 ligands tested. Thesedata are now being further examined to complete the profile of ORsligandinteraction sets and quantify the potency of the receptors byEC50. The results show that each individual receptor was activated byseveral different odorant molecules, which is in agreement with severalprevious reports. Furthermore, the data indicate that there are certainroles in the combination of receptor-ligand sets which are apparentlyrelated to the sequence similarity of receptors and the structure ofodorant molecules.57
- Page 1 and 2:
1 Symposium Chemosensory Receptors
- Page 3 and 4:
9 Symposium Chemosensory Receptors
- Page 5 and 6: 17 Givaudan LectureFISHING FOR NOVE
- Page 7 and 8: 25 Symposium Impact of Odorant Meta
- Page 10 and 11: 37 Poster Peripheral Olfaction and
- Page 12 and 13: 45 Poster Peripheral Olfaction and
- Page 14 and 15: 53 Poster Peripheral Olfaction and
- Page 16 and 17: 61 Poster Peripheral Olfaction and
- Page 18 and 19: 69 Poster Peripheral Olfaction and
- Page 20 and 21: 77 Poster Peripheral Olfaction and
- Page 22 and 23: 85 Poster Peripheral Olfaction and
- Page 24 and 25: 93 Poster Chemosensory Coding and C
- Page 26 and 27: 101 Poster Chemosensory Coding and
- Page 28 and 29: 109 Poster Chemosensory Coding and
- Page 30 and 31: 117 Poster Chemosensory Coding and
- Page 32 and 33: 125 Poster Chemosensory Coding and
- Page 34 and 35: 133 Poster Chemosensory Coding and
- Page 36 and 37: sniffing behavior. Furthermore, we
- Page 38 and 39: 149 Slide Chemosensory Coding and C
- Page 40 and 41: 157 Slide Taste ChemoreceptionHTAS2
- Page 42 and 43: 165 Poster Multimodal, Chemosensory
- Page 44 and 45: 173 Poster Multimodal, Chemosensory
- Page 46 and 47: 181 Poster Multimodal, Chemosensory
- Page 48 and 49: 189 Poster Multimodal, Chemosensory
- Page 50 and 51: 197 Poster Multimodal, Chemosensory
- Page 52 and 53: 205 Poster Multimodal, Chemosensory
- Page 54 and 55: 213 Poster Multimodal, Chemosensory
- Page 58 and 59: 229 Slide Molecular Genetic Approac
- Page 60 and 61: 237 Poster Central Olfaction and Ch
- Page 62 and 63: 245 Poster Central Olfaction and Ch
- Page 64 and 65: 253 Poster Central Olfaction and Ch
- Page 66 and 67: 261 Poster Central Olfaction and Ch
- Page 68 and 69: 269 Poster Central Olfaction and Ch
- Page 70 and 71: 277 Poster Central Olfaction and Ch
- Page 72 and 73: 285 Poster Central Olfaction and Ch
- Page 74 and 75: 293 Poster Central Olfaction and Ch
- Page 76 and 77: 301 Slide Central OlfactionOLFACTOR
- Page 78 and 79: 309 Poster Chemosensory Molecular G
- Page 80 and 81: 317 Poster Chemosensory Molecular G
- Page 82 and 83: 325 Poster Chemosensory Molecular G
- Page 84 and 85: 333 Poster Chemosensory Molecular G
- Page 86 and 87: 341 Poster Chemosensory Molecular G
- Page 88 and 89: 349 Poster Chemosensory Molecular G
- Page 90 and 91: 357 Poster Chemosensory Molecular G
- Page 92 and 93: 365 Poster Chemosensory Molecular G
- Page 94 and 95: 373 Symposium Olfactory Bulb Comput
- Page 96 and 97: 381 Symposium Presidential: Why Hav
- Page 98 and 99: 389 Poster Central Taste and Chemos
- Page 100 and 101: 397 Poster Central Taste and Chemos
- Page 102 and 103: 405 Poster Central Taste and Chemos
- Page 104 and 105: 413 Poster Central Taste and Chemos
- Page 106 and 107:
421 Poster Central Taste and Chemos
- Page 108 and 109:
429 Poster Central Taste and Chemos
- Page 110 and 111:
437 Symposium Neural Dynamics and C
- Page 112 and 113:
445 Poster Developmental, Neurogene
- Page 114 and 115:
453 Poster Developmental, Neurogene
- Page 116 and 117:
461 Poster Developmental, Neurogene
- Page 118 and 119:
469 Poster Developmental, Neurogene
- Page 120 and 121:
477 Poster Developmental, Neurogene
- Page 122 and 123:
485 Poster Developmental, Neurogene
- Page 124 and 125:
493 Poster Developmental, Neurogene
- Page 126 and 127:
501 Poster Developmental, Neurogene
- Page 128 and 129:
Brody, Carlos, 438Brown, R. Lane, 3
- Page 130 and 131:
Gilbertson, Timothy Allan, 63, 64,
- Page 132 and 133:
Klouckova, Iveta, 150Klyuchnikova,
- Page 134 and 135:
Ni, Daofeng, 93Nichols, Zachary, 35
- Page 136 and 137:
Sorensen, Peter W., 23, 288, 289Sou
- Page 138:
Zeng, Musheng, 466Zeng, Shaoqun, 26